Business

When it comes to making strategic AI investment deals, companies need to articulate their competitive advantage and how they view the market around them, says Jason Smith, venture acceleration fellow at MATTER.

Anervea.ai will develop and deploy an AI-powered suite of applications on Komodo's MapLab Enterprise platform.

The oncology-focused company will use the funds to boost manufacturing capacity, grow its commercial team and develop its next-generation Amma product.

The funds will be used to expand the company's enterprise-grade platform, aiOS, and accelerate the development of CARE, a clinical-grade foundation model.

The company aims to simplify the Medicaid enrollment and recertification process and will use the funds to expand into new states and scale its infrastructure.

The Australian company offers its members access to AI agents that analyze their health data, lifelong health plans, whole-body testing and a personal doctor.

The funds will be used to grow the company's engineering and commercial workforce, enhance product development, and accelerate integration with payers and providers.

The company will utilize the funds to accelerate the development of its clinical diagnostic platform and expand its partnerships with pharmaceutical and biotechnology firms.

The company offers mail-in semen analysis and vasectomy testing.

Patients can get more access to their healthcare information when AI is used to translate patient notes in their chart into a patient-friendly language and format, says Dr. Jonah Zaretsky, medical director at NYU Langone Hospital Brooklyn.